For decades, prostate cancer treatment was a “blind” science. Because standard imaging couldn’t reliably pinpoint the location of aggressive cells, doctors often treated the entire gland to be safe—frequently causing “collateral damage” to the nerves responsible for sexual and urinary function.
Today, the combination of multiparametric MRI (mpMRI) and NanoKnife technology has fundamentally changed this landscape. By using mpMRI as a high-definition GPS to map the tumor and NanoKnife to destroy it with non-thermal electrical pulses, physicians can now target the cancer while sparing the surrounding healthy tissue. This shift from “whole-gland” surgery to targeted focal therapy offers a new standard of care that prioritizes both cancer control and quality of life.
Enhanced Visibility: The mpMRI Revolution
The foundation of this change is multiparametric MRI (mpMRI). This high-resolution imaging allows physicians to see “inside” the prostate with unprecedented clarity.
- Risk Assessment: Doctors can now distinguish between slow-growing “indolent” cells and aggressive tumors.
- Targeted Biopsies: Instead of random samples, biopsies are now “fused” with MRI data to hit the exact suspicious area.
- Focal Mapping: This visibility allows for Focal Therapy—treating only the cancerous region while leaving the healthy portion of the prostate untouched.
The NanoKnife: Treatment Without Heat
While older focal therapies used extreme heat (HIFU) or freezing (Cryotherapy), the NanoKnife (Irreversible Electroporation or IRE) introduces a breakthrough biological mechanism.
How it Works: NanoKnife does not rely on temperature. Instead, it delivers ultra-short, high-voltage electrical pulses through thin needles. These pulses create “nanopores” (permanent microscopic holes) in the membranes of cancer cells, causing them to die naturally without damaging the surrounding tissue.
The “Lumpectomy” Concept: Much like a lumpectomy for breast cancer, NanoKnife treats the tumor with a small safety margin, preserving the organ and its vital functions.
Why the “Non-Thermal” Approach Matters
The prostate is surrounded by critical “roads” (nerves and vessels). Heat or cold can “leak” and damage these nearby structures. Because NanoKnife is non-thermal, it offers unique advantages:
- Nerve Preservation: The electrical pulses target cell membranes but leave the “scaffolding” of nerves and blood vessels intact.
- Precision Near the Urethra: It can safely treat tumors located near the urinary tube where heat-based treatments might cause scarring or incontinence.
- Rapid Recovery: Most procedures are outpatient, with patients returning to normal activity within days rather than weeks.
Clinical Evidence: The PRESERVE Study
Recent 2025/2026 data from the PRESERVE Trial (a pivotal study of intermediate-risk patients) has reinforced the effectiveness of this approach:
- Cancer Control: Over 84% of patients showed no clinically significant cancer in the treated zone at 12 months.
- Functional Success: 95% of patients remained pad-free (continent), and the vast majority maintained erectile function sufficient for intercourse.
Key Takeaway
NanoKnife is not a “one-size-fits-all” cure, but for men with localized, MRI-visible, intermediate-risk cancer, it represents a major leap forward. It offers a path to cancer control that prioritizes the patient’s lifestyle, recovery speed, and long-term physical function.
